HDAC8 and neuroblastoma: Selective inhibition of HDAC8 slows neuroblastoma growth, induces a more differentiated phenotype and serves as a potent enhancer of retinoic acid-mediated anti-neuroblastoma activity both in vitro and in vivo [10].